Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: Improvement with Venoruton

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 11, Issue 1, 2006, Pages 93-98

  Cesarone, Maria Rosaria ^a   Belcaro, Gianni ^b   Pellegrini, Luciano ^b   Ledda, Andrea ^b   Vinciguerra, Giulia ^b   Ricci, Andrea ^b   Gizzi, Giuseppe ^b   Ippolito, Edmondo ^b   Fano, Filiberto ^b   Dugall, Mark ^b   Acerbi, Giovanni ^b   Cacchio, Marisa ^b   Di Renzo, Andrea ^b   Hosoi, Morio ^b   Stuard, Stefano ^b   Corsi, Marcello ^b  

^a PAP/PEA Project   (Italy)

^b NONE

Author keywords

Chronic venous insufficiency; Endothelial cells; Venoruton; Venous disease

Indexed keywords

MONOXERUTIN;

ARTICLE; CELL COUNT; CHRONIC VEIN INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; LEG VEIN; MICROSCOPY; PERIPHERAL VEIN; PRIORITY JOURNAL; TRANSPLANTATION; TREATMENT OUTCOME; ULCER; VENOUS BLOOD;

BLOOD CIRCULATION; CELL COUNT; CHRONIC DISEASE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYETHYLRUTOSIDE; MALE; MIDDLE AGED; VASOCONSTRICTOR AGENTS; VENOUS INSUFFICIENCY;

EID: 33645705224     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840601100109     Document Type: Article

References (31)

1. Richardson P, Guinan E. Hepatic veno-occlusive disease following hematopoietic stem cell transplantation. Acta Haematol 106:57-68, 2001
2. Seguchi M, Hirabayashi N, Fujii Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 69:177-179, 2000
3. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 14:495-504, 1994
4. Cahill RA, Spitzer TR, Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18:177-184, 1996
5. Nadar SK, Lip GY, Lee KW, Blann AD. Circulating endothelial cells in acute ischaemic stroke. Thromb Haemost 94:707-712, 2005
6. Freestone B, Lip GY, Chong AY, et al. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Thromb Haemost 94:702-706, 2005
7. Chong AY, Lip GY, Freestone B, Blann AD. Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Fail. Sep 23; Epub ahead of print
8. Babal P, Kristova V, Cerna A, et al. Red wine polyphenols prevent endothelial damage induced by CCl(4) administration. Physiol Res 2005 Aug 5; Epub
9. Testa S, Manna A, Porcellini A. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation. Bone Marrow Transplant 18:383-388, 1996
10. Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: New insights into an old concept. Eur J Haematol 65:215-220, 2000
11. Dignat-George F, Sampol J, Lip G, Blann AD. Circulating endothelial cells: Realities and promises in vascular disorders. Pathophysiol Haemost Thromb 33:495-499, 2003/2004
12. Quilici J, Banzet N, Paule P, et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation 110:1586-1591, 2004
13. Woywodt A, Streiber F, de Groot K, et al. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361:206-210, 2003
14. Woywodt A, Schroeder M, Gwinner W, et al. Elevated numbers of circulating endothelial cells in renal transplant recipients. Transplantation 76:1-4, 2003
15. Woywodt A, Schroeder M, Mengel M, et al. Circulating endothelial cells are a novel marker of cyclosporine-induced endothelial damage. Hypertension 41:720-723, 2003
16. Woywodt A, Goldberg C, Scheer J, et al. A novel assay for the enumeration of circulating endothelial cells. Ann Hematol 83:491-494, 2004
17. Nurnberger W, Michelmann I, Burdach S, Gobel U. Endothelial dysfunction after bone marrow transplantation: Increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 76:61-65, 1998
18. Tansik R, Hong TJ, Spector NL, et al. Circulating endothelial cells and other biomarkers of angiogenesis in patients with lung, breast, and colorectal carcinomas. Proc Am Soc Clin Oncol 22:868, 2003
19. Langley RE, Bump EA, Quartuccio SG, et al. Radiation-induced apoptosis in microvascular endothelial cells. Br J Cancer 75:666-672, 1997
20. Rafii S. Circulating endothelial precursors: Mystery, reality, and promise. J Clin Invest 105:17-19, 2000
21. Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogenic hematopoietic stem cell transplantation. Blood 103:3603-3605, 2004
22. Woywodt A, Bahlmann FH, de Groot K, et al. Circulating endothelial cells: Life, death and detachment of the endothelial cell layer. Nephrol Dial Transplant 17:1728-1730, 2002
23. Cesarone MR, Belcaro G (editors). Fragilità vascolare e capillare. Turin: Minerva Medica; 2004
24. Cesarone M, Belcaro G, Pellegrini L, et al. Circulating endothelial cells (CECs) in peripheral venous blood are markers of endothelial damage in chronic venous insufficiency. Improvement with Venoruton. AKOM Web Journal, 2005, in press
25. Bancroft JD, Cook HC. Manual of Histological Techniques and their Diagnostic Application. Churchill Livingstone. p 328, 1994
26. Begermann H (editor). Ematologia, Padua: Piccin; 1981
27. Cesarone MR, Belcaro G, Ricci A, et al. Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins. Angiology 56:289-293, 2005
28. Cesarone MR, Belcaro G, Pellegrini L, et al. HR, 0-(beta-hydroxyethyl)- rutosides; (Venoruton): Rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: A prospective, controlled study. Angiology 56:165-172, 2005
29. Belcaro G, Cesarone MR, Bavera P, et al. HR (Venoruton 1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: An independent prospective, controlled, randomized trial. J Cardiovasc Pharmacol Ther 7(3):139-145, 2002
30. Petruzzellis V, Troccoli T, Candiani C, et al. Oxerutins (Venoruton): Efficacy in chronic venous insufficiency-a double-blind, randomized, controlled study. Angiology 53:257-263, 2002
31. Golden GJ. Venoruton in chronic venous insufficiency. Ugeskr Laeger 155:182-183, 1993